This report aims to provide a comprehensive presentation of the global market for B-Cell Chronic Lymphocytic Leukemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B-Cell Chronic Lymphocytic Leukemia Treatment. This report contains market size and forecasts of B-Cell Chronic Lymphocytic Leukemia Treatment in global, including the following market information:
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global B-Cell Chronic Lymphocytic Leukemia Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
AMG-319 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of B-Cell Chronic Lymphocytic Leukemia Treatment include AB Science SA, Amgen Inc., Celgene Corporation, Dynavax Technologies Corporation, Eisai, Elsalys Biotech SAS, F. Hoffmann-La Roche Ltd., iDD biotech SAS and Immunomedics, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the B-Cell Chronic Lymphocytic Leukemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Segment Percentages, by Type, 2022 (%)
AMG-319
ATTCK-20
IDD-002
JNJ-64052781
Lenalidomide
MAT-303
MT-3724
Others
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies B-Cell Chronic Lymphocytic Leukemia Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies B-Cell Chronic Lymphocytic Leukemia Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AB Science SA
Amgen Inc.
Celgene Corporation
Dynavax Technologies Corporation
Eisai
Elsalys Biotech SAS
F. Hoffmann-La Roche Ltd.
iDD biotech SAS
Immunomedics, Inc.
Johnson & Johnson
Juno Therapeutics Inc.
Molecular Templates Inc.
Noxxon Pharma AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of B-Cell Chronic Lymphocytic Leukemia Treatment, market overview.
Chapter 2: Global B-Cell Chronic Lymphocytic Leukemia Treatment market size in revenue.
Chapter 3: Detailed analysis of B-Cell Chronic Lymphocytic Leukemia Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of B-Cell Chronic Lymphocytic Leukemia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Overall Market Size
2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size: 2022 VS 2030
2.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top B-Cell Chronic Lymphocytic Leukemia Treatment Players in Global Market
3.2 Top Global B-Cell Chronic Lymphocytic Leukemia Treatment Companies Ranked by Revenue
3.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 B-Cell Chronic Lymphocytic Leukemia Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies B-Cell Chronic Lymphocytic Leukemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 B-Cell Chronic Lymphocytic Leukemia Treatment Players in Global Market
3.6.1 List of Global Tier 1 B-Cell Chronic Lymphocytic Leukemia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 B-Cell Chronic Lymphocytic Leukemia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Markets, 2022 & 2030
4.1.2 AMG-319
4.1.3 ATTCK-20
4.1.4 IDD-002
4.1.5 JNJ-64052781
4.1.6 Lenalidomide
4.1.7 MAT-303
4.1.8 MT-3724
4.1.9 Others
4.2 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue & Forecasts
4.2.1 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2023
4.2.2 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2024-2030
4.2.3 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2022 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue & Forecasts
5.2.1 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2023
5.2.2 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2024-2030
5.2.3 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2022 & 2030
6.2 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue & Forecasts
6.2.1 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2023
6.2.2 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2024-2030
6.2.3 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2030
6.3.2 US B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.3.3 Canada B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.3.4 Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2030
6.4.2 Germany B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.4.3 France B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.4.4 U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.4.5 Italy B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.4.6 Russia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.4.7 Nordic Countries B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.4.8 Benelux B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2030
6.5.2 China B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.5.3 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.5.4 South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.5.5 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.5.6 India B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2030
6.6.2 Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.6.3 Argentina B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2030
6.7.2 Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.7.3 Israel B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
6.7.5 UAE B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2018-2030
7 B-Cell Chronic Lymphocytic Leukemia Treatment Companies Profiles
7.1 AB Science SA
7.1.1 AB Science SA Company Summary
7.1.2 AB Science SA Business Overview
7.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.1.4 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.1.5 AB Science SA Key News & Latest Developments
7.2 Amgen Inc.
7.2.1 Amgen Inc. Company Summary
7.2.2 Amgen Inc. Business Overview
7.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.2.4 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.2.5 Amgen Inc. Key News & Latest Developments
7.3 Celgene Corporation
7.3.1 Celgene Corporation Company Summary
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.3.4 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.3.5 Celgene Corporation Key News & Latest Developments
7.4 Dynavax Technologies Corporation
7.4.1 Dynavax Technologies Corporation Company Summary
7.4.2 Dynavax Technologies Corporation Business Overview
7.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.4.4 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.4.5 Dynavax Technologies Corporation Key News & Latest Developments
7.5 Eisai
7.5.1 Eisai Company Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.5.4 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.5.5 Eisai Key News & Latest Developments
7.6 Elsalys Biotech SAS
7.6.1 Elsalys Biotech SAS Company Summary
7.6.2 Elsalys Biotech SAS Business Overview
7.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.6.4 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.6.5 Elsalys Biotech SAS Key News & Latest Developments
7.7 F. Hoffmann-La Roche Ltd.
7.7.1 F. Hoffmann-La Roche Ltd. Company Summary
7.7.2 F. Hoffmann-La Roche Ltd. Business Overview
7.7.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.7.4 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.8 iDD biotech SAS
7.8.1 iDD biotech SAS Company Summary
7.8.2 iDD biotech SAS Business Overview
7.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.8.4 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.8.5 iDD biotech SAS Key News & Latest Developments
7.9 Immunomedics, Inc.
7.9.1 Immunomedics, Inc. Company Summary
7.9.2 Immunomedics, Inc. Business Overview
7.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.9.4 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.9.5 Immunomedics, Inc. Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.10.4 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 Juno Therapeutics Inc.
7.11.1 Juno Therapeutics Inc. Company Summary
7.11.2 Juno Therapeutics Inc. Business Overview
7.11.3 Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.11.4 Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.11.5 Juno Therapeutics Inc. Key News & Latest Developments
7.12 Molecular Templates Inc.
7.12.1 Molecular Templates Inc. Company Summary
7.12.2 Molecular Templates Inc. Business Overview
7.12.3 Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.12.4 Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.12.5 Molecular Templates Inc. Key News & Latest Developments
7.13 Noxxon Pharma AG
7.13.1 Noxxon Pharma AG Company Summary
7.13.2 Noxxon Pharma AG Business Overview
7.13.3 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
7.13.4 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2018-2023)
7.13.5 Noxxon Pharma AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. B-Cell Chronic Lymphocytic Leukemia Treatment Market Opportunities & Trends in Global Market
Table 2. B-Cell Chronic Lymphocytic Leukemia Treatment Market Drivers in Global Market
Table 3. B-Cell Chronic Lymphocytic Leukemia Treatment Market Restraints in Global Market
Table 4. Key Players of B-Cell Chronic Lymphocytic Leukemia Treatment in Global Market
Table 5. Top B-Cell Chronic Lymphocytic Leukemia Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies B-Cell Chronic Lymphocytic Leukemia Treatment Product Type
Table 9. List of Global Tier 1 B-Cell Chronic Lymphocytic Leukemia Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 B-Cell Chronic Lymphocytic Leukemia Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2024-2030
Table 30. AB Science SA Company Summary
Table 31. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 32. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. AB Science SA Key News & Latest Developments
Table 34. Amgen Inc. Company Summary
Table 35. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 36. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Inc. Key News & Latest Developments
Table 38. Celgene Corporation Company Summary
Table 39. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 40. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Corporation Key News & Latest Developments
Table 42. Dynavax Technologies Corporation Company Summary
Table 43. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 44. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Dynavax Technologies Corporation Key News & Latest Developments
Table 46. Eisai Company Summary
Table 47. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 48. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Eisai Key News & Latest Developments
Table 50. Elsalys Biotech SAS Company Summary
Table 51. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 52. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Elsalys Biotech SAS Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Ltd. Company Summary
Table 55. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 56. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 58. iDD biotech SAS Company Summary
Table 59. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 60. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. iDD biotech SAS Key News & Latest Developments
Table 62. Immunomedics, Inc. Company Summary
Table 63. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 64. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Immunomedics, Inc. Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 68. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Juno Therapeutics Inc. Company Summary
Table 71. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 72. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Juno Therapeutics Inc. Key News & Latest Developments
Table 74. Molecular Templates Inc. Company Summary
Table 75. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 76. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Molecular Templates Inc. Key News & Latest Developments
Table 78. Noxxon Pharma AG Company Summary
Table 79. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 80. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Noxxon Pharma AG Key News & Latest Developments
List of Figures
Figure 1. B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Type in 2022
Figure 2. B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Application in 2022
Figure 3. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in 2022
Figure 8. By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 16. US B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 20. Germany B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 28. China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
